Renaissance Technologies
ADVB

Renaissance Technologies’s Advanced Biomed Inc ADVB Stock Holding History

Renaissance Technologies’s Portfolio ADVB Stock Details ADVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,230
Closed -$17.2K – 4037
2025
Q2 		$17.2K Buy
+1,230
New +$36.3K ﹤0.01% 3479

Other funds holding ADVB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies's ADVB Position: Q3 2025 in Review

Renaissance Technologies sold out of Advanced Biomed Inc (ADVB) in Q3 2025, closing a stake of 1,230 shares — an estimated $17.2K sold.

Renaissance Technologies first reported a position in ADVB in Q2 2025 and held it in 1 quarter. The position peaked at $17.2K in Q2 2025. 5 funds tracked by Wall St. Rank hold ADVB as of Q3 2025.

  • Renaissance Technologies reported no remaining Advanced Biomed Inc position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,230 Advanced Biomed Inc shares in Q3 2025, an estimated $17.2K.
  • Renaissance Technologies first reported a position in Advanced Biomed Inc in Q2 2025 and held it in 1 quarter.
  • Renaissance Technologies's Advanced Biomed Inc position peaked at $17.2K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Advanced Biomed Inc as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.